Phibro Animal Health Corporation PAHC
$ 21.95
0.64%
Quarterly report 2024-Q3
added 11-06-2024
Country |
USA |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Jack Bendheim |
Employees in the company |
1 700 |
Shares |
40.5 M |
Market Cap[1] |
$ 889 M |
EBITDA (LTM) |
$ 88.6 M |
P/E (LTM) |
109.67 |
P/S (LTM) |
0.93 |
EPS (LTM) |
0.21 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.